Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 575P9 | — |
Inappropriate reconstitution technique/ administered only the sterile water (diluent) component of Priorix to a patient; one of the pharmacists administered only the sterile water (diluent) component of Priorix to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 68-year-old male patient who received MMR (Priorix) (batch number 575P9, expiry date 07-OCT-2029) for prophylaxis. On 08-JAN-2026, the patient received Priorix. On 08-JAN-2026, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate reconstitution technique/ administered only the sterile water (diluent) component of Priorix to a patient) and inappropriate dose of vaccine administered (Verbatim: one of the pharmacists administered only the sterile water (diluent) component of Priorix to a patient). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-JAN-2026 The reporter wanted to know whether the Priorix components were sold separately.